Nogle patienter med Crohns sygdom eller colitis ulcerosa, som har fået Remicade, har udviklet en sjælden type cancer kaldet hepatosplenisk T- celle- lymfom.
42 Some patients with Crohn's disease or ulcerative colitis who have received Remicade have developed a rare type of cancer called Hepatosplenic T-cell Lymphoma.